RxDoctor Payments DataLook up a doctor →

Cristina Porchcurren, MD

Allergy/ Immunology · Camarillo, CANPI 1053314724

Payments from drug & device makers

$19,416in general payments, 2019–2025

Across 874 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$3K
  • AstraZeneca$3K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Amgen$1K
  • Sanofi$1K
  • Boehringer Ingelheim$1K
  • plus $8K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK206$3,090
AstraZeneca115$3,083
Regeneron Healthcare Solutions, Inc.76$1,567
Amgen(2 entities)53$1,357
Sanofi37$1,129
Boehringer Ingelheim50$1,070
Takeda Pharmaceuticals U.S.A., Inc.44$941
Pfizer46$908
Novartis42$786
Genentech USA, Inc.20$524
Kaleo, Inc.19$412
CSL Behring16$382
Optinose US, Inc.16$378
Pharming Healthcare, Inc.16$369
Biocryst US Sales Co., LLC9$345
Blueprint Medicines Corporation11$340
Incyte Corporation6$333
Grifols USA, LLC8$226
Ionis Pharmaceuticals, Inc.7$221
Octapharma USA, Inc.7$218
Merck10$198
ARS Pharmaceuticals Operations, Inc.9$196
Shire North American Group Inc4$179
AbbVie6$176
Gilead1$125
Sanofi-aventis U.S. LLC2$110
LEO Pharma Inc.5$107
Teva Pharmaceuticals USA, Inc.5$92
Cycle Pharmaceuticals Inc4$78
Aimmune Therapeutics, Inc.3$70
Hikma Pharmaceuticals USA4$66
Greer Laboratories, Inc.2$56
Biocryst Pharmaceuticals, Inc.2$50
Lilly USA, LLC2$47
Azurity Pharmaceuticals, Inc.1$32
Xeris Pharmaceuticals, Inc.1$26
Kedrion Biopharma, Inc.1$24
Covis Pharma GmbH1$23
Bio Products Laboratory USA, Inc.2$21
Arcutis Biotherapeutics, Inc.1$20
Galderma Laboratories, L.p.1$17
Alk-abello, Inc1$13
Organon2$8

How this compares

Too few allergy/ immunology providers in Californiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,047,777
Medicare patients
729
Services billed
80,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy/ immunology in Camarillo

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →